Microbial natural products as a source of antifungals.

Microbial metabolomics: replacing trial-and-error by the unbiased selection and ranking of targets. J Ind Microbiol Biotechnol (2005) 1.54

Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assay. J Nat Prod (2007) 1.10

The RIM101 pathway contributes to yeast cell wall assembly and its function becomes essential in the absence of mitogen-activated protein kinase Slt2p. Eukaryot Cell (2006) 1.07

Hassallidins, antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway. Proc Natl Acad Sci U S A (2014) 1.01

Antimicrobial blue light inactivation of Candida albicans: In vitro and in vivo studies. Virulence (2016) 0.93

Differential activities of three families of specific beta(1,3)glucan synthase inhibitors in wild-type and resistant strains of fission yeast. J Biol Chem (2010) 0.92

The Rho1p exchange factor Rgf1p signals upstream from the Pmk1 mitogen-activated protein kinase pathway in fission yeast. Mol Biol Cell (2008) 0.91

In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans. Antimicrob Agents Chemother (2009) 0.90

In-vitro antimicrobial activity of marine actinobacteria against multidrug resistance Staphylococcus aureus. Asian Pac J Trop Biomed (2012) 0.85

Phytochemical Analysis and Antimicrobial, Antinociceptive, and Anti-Inflammatory Activities of Two Chemotypes of Pimenta pseudocaryophyllus (Myrtaceae). Evid Based Complement Alternat Med (2012) 0.81

Synthesis and antifungal activity of (-)-(Z)-dysidazirine. Org Lett (2008) 0.78

SPK-843 (Aparts/Kaken). Curr Opin Investig Drugs (2005) 0.78

Does scientific evidence for the use of natural products in the treatment of oral candidiasis exist? A systematic review. Evid Based Complement Alternat Med (2015) 0.75

An invertebrate infection model for evaluating anti-fungal agents against dermatophytosis. Sci Rep (2017) 0.75

Progressive multifocal leukoencephalopathy in HIV infection presenting as Balint's syndrome. Neurology (1994) 2.14

Spongiform leucoencephalopathy after inhaling heroin. Lancet (1991) 1.68

Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother (2000) 1.66

[Melanotic medulloblastoma. Ultrastructural and histochemical study of a case]. Arch Neurobiol (Madr) (1990) 1.64

Continuous muscle fiber activity, peripheral neuropathy, and thymoma. Ann Neurol (1991) 1.48

Time window for clinical effectiveness of mass evacuation in a rat balloon model mimicking an intraparenchymatous hematoma. J Neurol Sci (2000) 1.44

Molecular analysis of Spanish patients with AMP deaminase deficiency. Muscle Nerve (2000) 1.42

[Diagnosis of Alzheimer's disease. Evaluation of senile plaques of the diffuse type]. Med Clin (Barc) (1992) 1.40

[Idiopathic thrombocytopenic purpura in 5 members of a family]. Sangre (Barc) (1994) 1.39

[Axilla skin biopsy in the diagnosis of Lafora's disease]. Neurologia (1994) 1.39

Production of a family of kinase-inhibiting lactones from fungal fermentations. J Antibiot (Tokyo) (1999) 1.37

Costs of infant-carrying in the cotton-top tamarin (Saguinus oedipus). Am J Primatol (1999) 1.35

Screening of antimicrobial activities in red, green and brown macroalgae from Gran Canaria (Canary Islands, Spain). Int Microbiol (2001) 1.32

Sex differential nectar secretion in protandrous Alstroemeria aurea (Alstroemeriaceae): is production altered by pollen removal and receipt? Am J Bot (1998) 1.25

Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain. Virchows Arch A Pathol Anat Histol (1982) 1.23

A new phenotype of dysferlinopathy with congenital onset. Neuromuscul Disord (2008) 1.20

Suprasellar chordoid glioma. Acta Neuropathol (2000) 1.20

Experimental test of quantum contextuality in neutron interferometry. Phys Rev Lett (2009) 1.19

Enhancement of antibiotic and secondary metabolite detection from filamentous fungi by growth on nutritional arrays. J Appl Microbiol (2008) 1.12

Screening of basidiomycetes for antimicrobial activities. Antonie Van Leeuwenhoek (2000) 1.08

[Sneddon's syndrome: its clinical characteristics and etiopathogenic factors]. Rev Clin Esp (1992) 1.07

[Thyroid myopathy. Effect of treatment with thyroid hormones]. An Med Interna (1990) 1.07

Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study. Ann Neurol (2001) 1.06

Patterns of antimicrobial activities from soil actinomycetes isolated under different conditions of pH and salinity. J Appl Microbiol (2003) 1.06

Diagnosis by axilla skin biopsy in an early case of Lafora's disease. J Neurol Neurosurg Psychiatry (1992) 1.06

[Hypothyroid myopathy. Clinico-pathologic study of 20 cases]. An Med Interna (1990) 1.06

Complex I defect in muscle from patients with Huntington's disease. Ann Neurol (1998) 1.04

Bacteriophage lambda-mediated transposon mutagenesis of phytopathogenic and epiphytic Erwinia species is strain dependent. Mol Gen Genet (1989) 1.00

Neuropathological studies on the toxic syndrome related to adulterated rapeseed oil in Spain. Brain (1983) 0.99

Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients. Leuk Res (2006) 0.99

Acute painful diabetic neuropathy following severe weight loss. Muscle Nerve (1996) 0.98

Multi-minicore disease--searching for boundaries: phenotype analysis of 38 cases. Ann Neurol (2000) 0.98

I-cell disease (mucolipidosis II):a report on its pathology. Acta Neuropathol (1975) 0.97

Wound-Induced RNase Activity in Sweet Potato : EVIDENCE FOR REGULATION AT TRANSCRIPTION. Plant Physiol (1982) 0.97

Bilateral striatal necrosis and MELAS associated with a new T3308C mutation in the mitochondrial ND1 gene. Biochem Biophys Res Commun (1997) 0.96

Fatal familial insomnia: clinical, neuropathological, and genetic description of a Spanish family. J Neurol Neurosurg Psychiatry (2000) 0.95

Intestinal pseudo-obstruction and urinary retention: cardinal features of a mitochondrial DNA-related disease. J Intern Med (2003) 0.93

Hyperkalaemic paralysis, neuropathy and persistent motor neuron discharges at rest in Addison's disease. J Neurol Neurosurg Psychiatry (1980) 0.93

Early-onset multisystem mitochondrial disorder caused by a nonsense mutation in the mitochondrial DNA cytochrome C oxidase II gene. Ann Neurol (2001) 0.91

Classification of oligodendroglial tumors based on histopathology criteria is a significant predictor of survival--clinical, radiological and pathologic long-term follow-up analysis. Clin Neuropathol (2009) 0.91

Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases. J Clin Immunol (1998) 0.90

The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organisms. Syst Appl Microbiol (2000) 0.89

Arundifungin, a novel antifungal compound produced by fungi: biological activity and taxonomy of the producing organisms. Int Microbiol (2001) 0.88

Mitochondrial dysfunction associated with a mutation in the Notch3 gene in a CADASIL family. Neurology (2001) 0.88

Novel mutations in patients with McArdle disease by analysis of skeletal muscle mRNA. J Med Genet (2009) 0.87

Subcortical arteriosclerotic encephalopathy (Binswanger's disease): a report of five patients. Acta Neurol Scand (1987) 0.87

Haemangiopericytoma presenting with acute intracerebral haemorrhage. Acta Neurochir (Wien) (2007) 0.86

Encephalopathy, petechiae, and acrocyanosis with ethylmalonic aciduria associated with muscle cytochrome c oxidase deficiency. J Pediatr (1994) 0.86

Hereditary motor and sensory neuropathy type II. Clinicopathological study of a family. Brain (1986) 0.86

PDH E1β deficiency with novel mutations in two patients with Leigh syndrome. J Inherit Metab Dis (2009) 0.86

Paraganglioma of the cauda equina. Cancer (1983) 0.85

Sporadic MERRF/MELAS overlap syndrome associated with the 3243 tRNA(Leu(UUR)) mutation of mitochondrial DNA. Muscle Nerve (1996) 0.84

Lack of gastrointestinal symptoms in a 60-year-old patient with MNGIE. Neurology (2004) 0.84

Mitochondrial DNA deletion in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes (MELAS) and Fanconi's syndrome. Pediatr Neurol (1995) 0.84

Increased muscle nucleoside levels associated with a novel frameshift mutation in the thymidine phosphorylase gene in a Spanish patient with MNGIE. Neuromuscul Disord (2005) 0.84

Complete surgical resection of high-grade astroblastoma with long time survival: case report and review of the literature. Neurocirugia (Astur) (2006) 0.83

Muscle carnitine deficiency and lipid storage myopathy in patients with mitochondrial myopathy. Muscle Nerve (1993) 0.83

Antimicrobial activity of viridiofungins. J Antibiot (Tokyo) (1997) 0.83

Autosomal recessive hereditary sensory neuropathy with spastic paraplegia. Brain (1994) 0.83

Long-distance distribution of genuine energy-time entanglement. Nat Commun (2013) 0.83

Subependymoma of the lateral ventricle. Surg Neurol (1981) 0.82

Molecular analysis in Spanish patients with muscle carnitine palmitoyltransferase deficiency. Muscle Nerve (1999) 0.82

Histochemical study of the vastus lateralis muscle fibre types of athletes. J Physiol Biochem (1998) 0.82

Comparison of genotypic and phenotypic techniques for assessing the variability of the fungus Epicoccum nigrum. J Appl Microbiol (2002) 0.81

Diversity of actinomycetes and fungi on seaweeds from the Iberian coasts. Microbiologia (1994) 0.81

Clinical heterogeneity in two pedigrees with the 3243 bp tRNA(Leu(UUR)) mutation of mitochondrial DNA. Acta Neurol Scand (1995) 0.81

Long-term persistence of fascia lata patch graft in glaucoma drainage device surgery. Eur J Ophthalmol (2005) 0.81

Dominantly inherited motor and sensory neuropathy type I. Genetic, clinical, electrophysiological and pathological features in four families. J Neurol Sci (1983) 0.81

[Lymphomatosis cerebri as the cause of leukoencephalopathy]. Rev Neurol (2008) 0.81

Normal angiogram after myocardial infarction in young patients: a prospective clinical-angiographic and long-term follow-up study. Int J Cardiol (1997) 0.80

Myopathy with multiple minicore--report of two siblings. J Neurol Sci (1980) 0.80

Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum. J Appl Microbiol (2001) 0.80

Two pathogenic mutations in the mitochondrial DNA tRNA Leu(UUR) gene (T3258C and A3280G) resulting in variable clinical phenotypes. Neuromuscul Disord (2003) 0.79

[Unusual cortical compromise in a case of Wernicke's encephalopathy]. Rev Neurol (2006) 0.79

Subacute myelo-optic neuropathy (SMON). First neuro-pathological report outside Japan. J Neurol Sci (1982) 0.79

[Early erythropoietin use for the prevention of anemia in infant premature]. Rev Med Chil (2000) 0.79

[Neonatal hypotonia of muscular origin: analysis of 50 cases]. Neurologia (2001) 0.79

Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201-995 before transsphenoidal surgery. J Neurosurg (1994) 0.78

Two homozygous mutations (R193W and 794/795 delAA) in the myophosphorylase gene in a patient with McArdle's disease. Hum Mutat (2000) 0.78

Intracranial seeding from an intramedullary malignant astrocytoma. Surg Neurol (1986) 0.78

Multiple intracranial arterial occlusions (moyamoya disease) in patients with neurofibromatosis. One case report with autopsy. Acta Neurochir (Wien) (1978) 0.78

Herpes simplex brainstem encephalitis with a relapsing course. J Neurol (1994) 0.78

A double homozygous mutation in the POMT1 gene involving exon skipping gives rise to Walker-Warburg syndrome in two Spanish Gypsy families. Clin Genet (2009) 0.77

A homozygous missense mutation (A659D) in the myophosphorylase gene in a Spanish patient with McArdle's disease. Neuromuscul Disord (2000) 0.77

Toxic epidemic syndrome: musculoskeletal manifestations. J Rheumatol (1984) 0.77

Autosomal dominant congenital fibre type disproportion: a clinicopathological and imaging study of a large family. Brain (2005) 0.77

A missense mutation T487N in the myophosphorylase gene in a Spanish patient with McArdle's disease. Neuromuscul Disord (2000) 0.77

[Whipple's disease confined to the brain. A clinical case with pathological confirmation at necropsy]. Rev Neurol (2004) 0.77

A missense mutation W797R in the myophosphorylase gene in a Spanish patient with McArdle's disease. Muscle Nerve (2000) 0.77

A study of IgE in immunoglobulin preparations for intravenous administration. I. IgE in intravenous IgG. Vox Sang (1986) 0.77

Chaetomella acutiseta produces chaetomellic acids A and B which are reversible inhibitors of farnesyl-protein transferase. Appl Microbiol Biotechnol (1993) 0.76

Respiratory chain enzyme defects in patients with idiopathic inflammatory myopathy. Ann Rheum Dis (1995) 0.76

Cosegregation of the mitochondrial DNA A1555G and G4309A mutations results in deafness and mitochondrial myopathy. Muscle Nerve (2002) 0.76